Latest News
September 26, 2023
Older women who get mammograms risk overdiagnosis
September 26, 2023
M. Alexander Otto, PA, MMS
M. Alexander Otto, PA, MMS
September 26, 2023
MDedge Hematology and Oncology
September 26, 2023
Omitting sentinel lymph node biopsy safe for some early breast cancers
September 26, 2023
Megan Brooks
Megan Brooks
September 26, 2023
MDedge Hematology and Oncology
September 26, 2023
Adhering to endocrine therapy is hard. What can be done?
September 26, 2023
Nancy A. Melville
Nancy A. Melville
September 26, 2023
MDedge Hematology and Oncology
September 26, 2023
High-risk colon polyps detected at screening colonoscopy linked to liver cancer death
September 26, 2023
Megan Brooks
Megan Brooks
September 26, 2023
MDedge Hematology and Oncology
Conference Coverage
September 20, 2023
Therapeutic vaccine shows promise in treating lung cancer
September 20, 2023
Aude Lecrubier
Aude Lecrubier
September 20, 2023
IASLC World Conference on Lung Cancer
MDedge Hematology and Oncology
September 18, 2023
Nivolumab/Ipillimumab combo demonstrates long-term efficacy in NSCLC
September 18, 2023
Jim Kling
Jim Kling
September 18, 2023
IASLC World Conference on Lung Cancer
MDedge Hematology and Oncology
September 14, 2023
Proposed TNM update could shift staging for lung cancers
September 14, 2023
Liam Davenport
Liam Davenport
September 14, 2023
IASLC World Conference on Lung Cancer
MDedge Hematology and Oncology
September 14, 2023
Neoadjuvant durvalumab does not affect surgical outcomes in NSCLC: Study
September 14, 2023
Jim Kling
Jim Kling
September 14, 2023
IASLC World Conference on Lung Cancer
MDedge Hematology and Oncology
September 14, 2023
Debate: Should smoldering myeloma be treated?
September 14, 2023
M. Alexander Otto
M. Alexander Otto
September 14, 2023
SOHO: Society of Hematologic Oncology
MDedge Hematology and Oncology
September 14, 2023
Osimertinib plus chemo ups PFS, toxicity in first line
September 14, 2023
Liam Davenport
Liam Davenport
September 14, 2023
IASLC World Conference on Lung Cancer
MDedge Hematology and Oncology
Opinion
September 20, 2023
New ‘C word’: Cure should be the goal for patients with lung cancer
September 20, 2023
Mark G. Kris, MD
Mark G. Kris, MD
September 20, 2023
MDedge Hematology and Oncology

September 20, 2023
Two landmark papers change treatment paradigm for advanced endometrial cancer
September 20, 2023
Maurie Markman, MD
Maurie Markman, MD
September 20, 2023
MDedge Hematology and Oncology

September 18, 2023
The safety of vaginal estrogen in breast cancer survivors
September 18, 2023
Andrew M. Kaunitz, MD
Andrew M. Kaunitz, MD
September 18, 2023
MDedge Hematology and Oncology
COVID-19 News
September 1, 2023
Q&A: What to know about the new BA 2.86 COVID variant
September 1, 2023
Kara Grant
Kara Grant
September 1, 2023
MDedge Hematology and Oncology
May 18, 2023
Review supports continued mask-wearing in health care visits
May 18, 2023
Jay Croft
Jay Croft
May 18, 2023
MDedge Hematology and Oncology
May 18, 2023
COVID emergency over, but hundreds are still dying weekly
May 18, 2023
Claire Sibonney
Claire Sibonney
May 18, 2023
MDedge Hematology and Oncology
March 21, 2023
COVID can mimic prostate cancer symptoms
March 21, 2023
David King Keller, PhD
David King Keller, PhD
March 21, 2023
MDedge Hematology and Oncology
News from the FDA/CDC

August 31, 2023
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
August 31, 2023
Kerry Dooley Young
Kerry Dooley Young
August 31, 2023
MDedge Hematology and Oncology

August 15, 2023
FDA approves elranatamab for multiple myeloma
August 15, 2023
Sharon Worcester, MA
Sharon Worcester, MA
August 15, 2023
MDedge Hematology and Oncology

August 14, 2023
FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancer
August 14, 2023
Sharon Worcester, MA
Sharon Worcester, MA
August 14, 2023
MDedge Hematology and Oncology
Policy & Practice

September 20, 2023
Nationwide hematologists shortage: What’s being done?
September 20, 2023
Myles Starr
Myles Starr
September 20, 2023
MDedge Hematology and Oncology
September 19, 2023
Do doctors have a legal right to work from home because of health issues or disability?
September 19, 2023
Alicia Gallegos
Alicia Gallegos
September 19, 2023
MDedge Hematology and Oncology
September 19, 2023
The top tax breaks that physicians use
September 19, 2023
Beth Braverman
Beth Braverman
September 19, 2023
MDedge Hematology and Oncology

September 15, 2023
Artificial intelligence in your office
September 15, 2023
Joseph S. Eastern, MD
Joseph S. Eastern, MD
September 15, 2023
MDedge Hematology and Oncology
Medicine’s Lighter Side
Livin' on the MDedge

June 29, 2023
Placebo effect can be found in a cup of coffee
June 29, 2023
Lucas Franki, et al
Lucas Franki, et al
June 29, 2023
MDedge Hematology and Oncology

June 22, 2023
Low-calorie tastes sweeter with a little salt
June 22, 2023
Lucas Franki, et al
Lucas Franki, et al
June 22, 2023
MDedge Hematology and Oncology

June 15, 2023
The road to weight loss is paved with collusion and sabotage
June 15, 2023
Lucas Franki, et al
Lucas Franki, et al
June 15, 2023
MDedge Hematology and Oncology

June 8, 2023
The enemy of carcinogenic fumes is my friendly begonia
June 8, 2023
Lucas Franki, et al
Lucas Franki, et al
June 8, 2023
MDedge Hematology and Oncology
Clinical Edge Journal Scan
August 24, 2023
Commentary: Age and breast cancer, and cardiometabolic comorbidities, September 2023
August 24, 2023
Erin Roesch, MD
Erin Roesch, MD
August 24, 2023
MDedge Hematology and Oncology
July 25, 2023
Commentary: Node irradiation, HER2+ treatment, and diet in BC, August 2023
July 25, 2023
Erin Roesch, MD
Erin Roesch, MD
July 25, 2023
MDedge Hematology and Oncology
June 27, 2023
Commentary: Advances in HER2 advanced breast cancer, July 2023
June 27, 2023
Erin Roesch, MD
Erin Roesch, MD
June 27, 2023
MDedge Hematology and Oncology
May 24, 2023
Commentary: Pregnancy, neoadjuvant treatment, and sexual function after BC diagnosis, June 2023
May 24, 2023
Erin Roesch, MD
Erin Roesch, MD
May 24, 2023
MDedge Hematology and Oncology
Conference ReCAP
June 22, 2023
Key Abstracts in Early Breast Cancer From ASCO 2023
June 22, 2023
Harold J. Burstein, MD, PhD
Harold J. Burstein, MD, PhD
June 22, 2023
MDedge Hematology and Oncology
June 22, 2023
Key Abstracts in Metastatic Breast Cancer From ASCO 2023
June 22, 2023
June 22, 2023
MDedge Hematology and Oncology
May 4, 2023
Advances in Breast Cancer From AACR 2023
May 4, 2023
Kathy D. Miller, MD
Kathy D. Miller, MD
May 4, 2023
MDedge Hematology and Oncology
May 4, 2023
Key Takeaways in Early Breast Cancer From AACR 2023
May 4, 2023
Kathy D. Miller, MD
Kathy D. Miller, MD
May 4, 2023
MDedge Hematology and Oncology
ReCAP
September 5, 2023
Optimizing Biomarker Testing in Non–Small Cell Lung Cancer
September 5, 2023
Thomas E. Stinchcombe, MD
Thomas E. Stinchcombe, MD
September 5, 2023
MDedge Hematology and Oncology
May 1, 2023
Endocrine Therapy Resistance in HR+/HER2- Breast Cancer
May 1, 2023
Jennifer K. Litton, MD
Jennifer K. Litton, MD
May 1, 2023
MDedge Hematology and Oncology
March 29, 2023
Optimal Use of CDK4/6 Inhibitors in Breast Cancer
March 29, 2023
Virginia Kaklamani, MD; Harold J. Burstein, MD, PhD
Virginia Kaklamani, MD; Harold J. Burstein, MD, PhD
March 29, 2023
MDedge Hematology and Oncology
March 23, 2023
Frontline Treatment for Advanced HR+/HER2- Breast Cancer
March 23, 2023
Kevin Kalinsky, MD
Kevin Kalinsky, MD
March 23, 2023
MDedge Hematology and Oncology